Live Analyst Rating Changes 1515 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/David Saxon
NDM
David Saxon
Needham
Wall Street Analyst
★★★☆☆
#838
on 13Foresight · ranked by our own returns
53%
Success Rate
+0.9%
Average Return
8 of 15 calls profitable · -1.1% vs benchmark
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 53% of David Saxon's ratings turned a profit when each position was held for 1 year — averaging +0.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

63 Buy 47 Hold 0 Sell
David's Stock Coverage 16 ratings · 2026-06-19
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
GKOS
Glaukos
 Jun 17, 2026 BUY Strong Buy
+5.9% avg upside
20 analysts
$150.00
14.85% Upside
 ·
COO
Cooper Co
 Jun 05, 2026 BUY Buy
+102.5% avg upside
21 analysts
$86.00
30.46% Upside
 +0.0%
SIBN
SI-Bone
 Jun 03, 2026 BUY Strong Buy
+60.9% avg upside
18 analysts
$27.00
70.53% Upside
 ·
STAA
Staar Surgical
 May 14, 2026 HOLD Hold
+14.3% avg upside
16 analysts
 — -10.5%
GMED
Globus Medical
 May 08, 2026 BUY Strong Buy
+22.3% avg upside
24 analysts
$117.00
47.69% Upside
 +3.1%
NVST
Envista Holdings
 May 07, 2026 HOLD Buy
+13.6% avg upside
19 analysts
$27.00
4.23% Upside
 -4.4%
SGHT
Sight Sciences
 May 07, 2026 HOLD Buy
+54.1% avg upside
13 analysts
 — -7.2%
RXST
RxSight
 May 07, 2026 BUY Hold
+133.2% avg upside
13 analysts
$11.00
132.64% Upside
 +3.5%
CH:ALC
Alcon
 May 06, 2026 BUY Buy
+34.9% avg upside
35 analysts
$75.29
45.04% Upside
 ·
AZTA
Azenta
 May 06, 2026 BUY Buy
+102.3% avg upside
13 analysts
$33.00
41.52% Upside
 +23.4%
ATEC
Alphatec Holdings
 May 06, 2026 BUY Strong Buy
+116.6% avg upside
22 analysts
$14.00
59.01% Upside
 +15.7%
XRAY
DENTSPLY SIRONA
 May 06, 2026 HOLD Buy
+171.7% avg upside
25 analysts
 — -5.1%
CYRX
CryoPort
 May 05, 2026 BUY Strong Buy
-3.8% avg upside
15 analysts
$15.00
0.01% Downside
 +7.8%
IRTC
Irhythm Technologies
 May 01, 2026 BUY Strong Buy
+62.0% avg upside
19 analysts
$255.00
143.69% Upside
 ·
ALGN
Align Tech
 Apr 30, 2026 HOLD Strong Buy
+58.0% avg upside
21 analysts
$184.00
1.08% Upside
 -1.4%
BLCO
Bausch + Lomb Corporation
 Apr 29, 2026 HOLD Buy
+30.6% avg upside
19 analysts
 — -1.0%
🔒 11 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
David Saxon — Frequently Asked Questions
How accurate are David Saxon's stock ratings?
Based on the calls 13Foresight could measure, about 53% of David's ratings were profitable over a one-year hold, with an average return of +0.9% per rating, or -1.1% versus the S&P 500. We score every analyst the same way, from historical prices.
How is David ranked on 13Foresight?
David Saxon is currently ranked #838 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does David cover?
David most recently has ratings on GKOS, COO, SIBN, STAA, GMED, NVST, SGHT, RXST, CH:ALC, AZTA, ATEC, XRAY and 4 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.